Journal article
Uptake and Transport of Ultrafine Nanoparticles (Quantum Dots) in the Nasal Mucosa
Molecular pharmaceutics, Vol.18(1), pp.429-440
01/04/2021
DOI: 10.1021/acs.molpharmaceut.0c01074
PMID: 33346666
Abstract
A wide variety of colloidal delivery systems, including polymeric nanoparticles, metal colloids, liposomes, and microemulsions have been reported to enhance the delivery of therapeutic agents across the nasal mucosa. The mechanisms involved in the uptake of these nanomaterials, especially ultrafine nanomaterials (diameters < 20 nm) through the nasal mucosa are not well understood. Fluorescent quantum dots (QDs) were used to investigate the uptake of ultrafine nanoparticles by bovine respiratory and olfactory mucosal tissues following in vitro exposure, and an inductively coupled plasma optical emission spectroscopy method was developed to quantify the amount of QDs localized within the tissues. QDs do not biodegrade or release their core materials and, as a result, this method allowed for the direct quantification of the nanoparticles themselves, rather than the measurement of a potentially dissociated drug or label. The results demonstrated that carboxylate-modified QDs (COOH-QDs) showed similar to 2.5-fold greater accumulation in the epithelial and submucosal regions of olfactory tissues compared to that in respiratory tissues. Endocytic inhibitory studies showed that clathrin-dependent endocytosis, macropinocytosis, and caveolae-dependent endocytic process are all involved in the uptake of COOH-QDs into the respiratory tissues. In olfactory tissues, clathrin-dependent endocytosis is the major endocytic pathway involved in the uptake of COOH-QDs. Additional energy-independent pathways also appeared to allow the transfer of COOH-QDs within the olfactory mucosa. When polyethylene glycol-modified QDs known as PEGylated QDs (PEG-QDs) of similar size, similar to 15 nm, were investigated, no nanoparticles were detected in the tissues suggesting that the PEG corona limits the interactions with endocytic and other uptake processes in the nasal epithelium. The capacity for nanoparticle uptake observed in the nasal mucosa, along with the ability of significant numbers of nanoparticles to enter the olfactory tissues using nonenergy-dependent pathways show that the pathways for ultrafine nanoparticle uptake in the nasal tissues have both drug delivery and toxicologic consequences. This places an increased importance on the careful selection of nanoparticle components and drugs intended for intranasal administration.
Details
- Title: Subtitle
- Uptake and Transport of Ultrafine Nanoparticles (Quantum Dots) in the Nasal Mucosa
- Creators
- Bhanu C. Bejgum - University of IowaMaureen D. Donovan - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Molecular pharmaceutics, Vol.18(1), pp.429-440
- Publisher
- Amer Chemical Soc
- DOI
- 10.1021/acs.molpharmaceut.0c01074
- PMID
- 33346666
- ISSN
- 1543-8384
- eISSN
- 1543-8392
- Number of pages
- 12
- Grant note
- Institute for Clinical and Translation Science (ICTS), University of Iowa
- Language
- English
- Date published
- 01/04/2021
- Academic Unit
- Pharmaceutical Sciences and Experimental Therapeutics
- Record Identifier
- 9984365901702771
Metrics
3 Record Views